Earth Science Tech (ETST) Return on Capital Employed (2012 - 2026)
Earth Science Tech (ETST) posted Return on Capital Employed of 50.12% for Q1 2026, down 12.21% on a QoQ basis from 57.1% in Q4 2025, and down 5626.0% year-over-year from 0.91% in Q1 2025.
Earth Science Tech (ETST) Return on Capital Employed (2012 - 2026) Analysis & Trends
Earth Science Tech's Return on Capital Employed history runs 13 years deep, the most recent figure standing at 50.12% for Q1 2026.
- Quarterly Return on Capital Employed fell 5626.0% year-over-year to 50.12% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 50.12% (down 5626.0% YoY) and the FY2026 annual result came in at 54.33%, down 9379.0% from the prior year.
- Return on Capital Employed was 50.12% for Q1 2026 at Earth Science Tech, down from 57.1% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 106.38% in Q1 2025 and bottomed at 287.87% in Q1 2023.
- A 5-year average of 30.93% and a median of 50.12% in 2026 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed plunged 30025 bps — and 2024, when it surged 33302 bps.
- Earth Science Tech's Return on Capital Employed stood at 92.12% in 2022, then plunged by 74 bps to 24.13% in 2023, then surged by 222 bps to 77.65% in 2024, then fell by 26 bps to 57.1% in 2025, then declined by 12 bps to 50.12% in 2026.
- Business Quant data shows ETST's Return on Capital Employed at 50.12% in Q1 2026, 57.1% in Q4 2025, and 50.9% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn | 50.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.12% |
| Dec 31, 2025 | 57.10% |
| Sep 30, 2025 | 50.90% |
| Jun 30, 2025 | 65.19% |
| Mar 31, 2025 | 106.38% |
| Dec 31, 2024 | 77.65% |
| Sep 30, 2024 | 74.23% |
| Jun 30, 2024 | 71.55% |
| Mar 31, 2024 | 45.15% |
| Dec 31, 2023 | 24.13% |
| Sep 30, 2023 | 11.56% |
| Jun 30, 2023 | -14.27% |
| Mar 31, 2023 | -287.87% |
| Dec 31, 2022 | 92.12% |
| Sep 30, 2022 | 45.86% |
| Jun 30, 2022 | 43.58% |
| Mar 31, 2022 | 12.38% |
| Dec 31, 2021 | 19.71% |
| Sep 30, 2021 | 19.53% |
| Jun 30, 2021 | 86.13% |